Your browser doesn't support javascript.
loading
Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial.
Abdullahi, Shehu U; Jibir, Binta W; Bello-Manga, Halima; Gambo, Safiya; Inuwa, Hauwa; Tijjani, Aliyu G; Idris, Nura; Galadanci, Aisha; Hikima, Mustapha S; Galadanci, Najibah; Borodo, Awwal; Tabari, Abdulkadir M; Haliru, Lawal; Suleiman, Aisha; Ibrahim, Jamila; Greene, Brittany C; Ghafuri, Djamila L; Rodeghier, Mark; Slaughter, James C; Kirkham, Fenella J; Neville, Kathleen; Kassim, Adetola; Trevathan, Edwin; Jordan, Lori C; Aliyu, Muktar H; DeBaun, Michael R.
Afiliação
  • Abdullahi SU; Department of Pediatrics, Bayero University/Aminu Kano Teaching Hospital, Kano, Nigeria.
  • Jibir BW; Department of Pediatrics, Hasiya Bayero Pediatric Hospital, Kano, Nigeria.
  • Bello-Manga H; Department of Haematology and Blood Transfusion, Kaduna State University/Barau Dikko Teaching Hospital, Kaduna, Nigeria.
  • Gambo S; Department of Pediatrics, Murtala Mohammed Specialist Hospital, Kano, Nigeria.
  • Inuwa H; Department of Pediatrics, Bayero University/Aminu Kano Teaching Hospital, Kano, Nigeria.
  • Tijjani AG; Department of Pediatrics, Murtala Mohammed Specialist Hospital, Kano, Nigeria.
  • Idris N; Department of Pediatrics, Murtala Mohammed Specialist Hospital, Kano, Nigeria.
  • Galadanci A; Department of Haematology and Blood Transfusion, Bayero University/Aminu Kano Teaching Hospital, Kano, Nigeria.
  • Hikima MS; Department of Radiology, Muhammad Abdullahi Wase Teaching Hospital, Kano, Nigeria.
  • Galadanci N; Department of Epidemiology, School of Public health, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Borodo A; Department of Medicine, Murtala Mohammed Specialist Hospital, Kano, Nigeria.
  • Tabari AM; Department of Radiology, Kaduna State University, Barau Dikko Teaching Hospital, Kaduna, Nigeria.
  • Haliru L; Department of Pediatrics, Kaduna State University, Barau Dikko Teaching Hospital, Kaduna, Nigeria.
  • Suleiman A; Department of Pediatrics, Kaduna State University, Barau Dikko Teaching Hospital, Kaduna, Nigeria.
  • Ibrahim J; Department of Pediatrics, Murtala Mohammed Specialist Hospital, Kano, Nigeria.
  • Greene BC; Department of Pediatrics, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Ghafuri DL; Department of Pediatrics, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Rodeghier M; Rodeghier Consultants, Chicago, IL, USA.
  • Slaughter JC; Department of Biostatistics, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Kirkham FJ; Developmental Neurosciences, University College London Great Ormond Street Institute of Child Health, London, UK.
  • Neville K; Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Kassim A; Department of Hematology and Oncology, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Pediatrics, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville,
  • Trevathan E; Vanderbilt Institute for Global Health, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Pediatrics, Neurology, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center,
  • Jordan LC; Department of Pediatrics, Neurology, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Aliyu MH; Vanderbilt Institute for Global Health, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, TN, USA.
  • DeBaun MR; Vanderbilt Institute for Global Health, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Pediatrics, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville,
Lancet Haematol ; 9(1): e26-e37, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34971579
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acidente Vascular Cerebral / Anemia Falciforme Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies Limite: Child, preschool / Female / Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acidente Vascular Cerebral / Anemia Falciforme Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies Limite: Child, preschool / Female / Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2022 Tipo de documento: Article